Although many viral receptors have been identified, the ways in which they interact with their cognate viruses are not understood at the molecular level. We have determined the X-ray structure of a complex between calcium-containing modules of the very low-density lipoprotein receptor and the minor group human rhinovirus HRV2. The receptor binds close to the icosahedral five-fold vertex, with only one module per virus protomer. The binding face of this module is defined by acidic calcium-chelating residues and, in particular, by an exposed tryptophan that is highly conserved. The attachment site on the virus involves only residues from VP1, particularly a lysine strictly conserved in all minor group HRVs. The disposition of the attached ligand-binding repeats around the five-fold axis, together with the proximity of the N-and C-terminal ends of adjacent modules, suggests that more than one repeat in a single receptor molecule might attach simultaneously.
Specific recognition of a virus by a suitable cell surface receptor is a condition for infection to occur, and cells devoid of surface structures appropriate for viral attachment fail to become infected. Viruses bind to the extracellular domains of their receptors. The receptors are usually anchored in the membrane via a hydrophobic region or an attached lipid. Most often receptors also contain a cytoplasmic domain with adapter protein-binding motifs that mediate clathrin-dependent endocytosis. Despite the importance of virus-receptor interactions in viral infection, the only high-resolution structure of a virus-receptor complex reported so far is that of foot-and-mouth disease virus decorated with a heparan sulfate-derived oligosaccharide acting as an alternative receptor 1 .
Human rhinoviruses (HRV), members of the Picornaviridae family, are a main cause of common cold infections. Of the >100 serotypes, 91 (members of the major group) use intercellular adhesion molecule 1 (ICAM-1), a member of the immunoglobulin superfamily, for cell entry 2, 3 , whereas 10 (members of the minor group) bind the lowdensity lipoprotein receptor (LDLR), very LDLR (VLDLR) (Fig. 1) and LDLR-related protein (LRP) 4, 5 . These are closely related surface receptors implicated in endocytosis of a variety of ligands and in signal transduction 6 . LDLR, the prototype of the family, can be divided into five domains 7, 8 (Fig. 1) . The N-terminal ligand-binding domain has seven imperfect direct repeats, L1-L7. Each repeat is ∼40 amino acids long, and its structure is stabilized by a Ca 2+ ion and six highly conserved cysteines that form disulfide bonds 7 . C-terminal to the ligandbinding domain lies the EGF-precursor domain with three other repeats (A-C) with sequences similar to that of the epidermal growth factor (EGF) precursor. A region between repeats B and C has a β-propeller fold containing Tyr-Trp-Thr-Asp motifs. The β-propeller structure is implicated in low pH-induced release of the ligands in endosomes 8, 9 . Differences among the types and number of repeats allow members of the LDLR family to recognize a large variety of structurally and functionally diverse ligands 10 .
The icosahedral capsids of picornaviruses are composed of 60 copies each of four viral coat proteins VP1-VP4 following a T = 1 organization 11 . A prominent feature of the HRV shell is a star-shaped dome on each of the five-fold axes surrounded by a large depression or 'canyon.' A hydrophobic pocket in the base of the canyon is often occupied by natural factors, such as cell-derived fatty acids, which can be replaced by antiviral compounds 12 . Cryo-electron microscopy (cryo-EM) image reconstructions of complexes between human rhinovirus serotype 2 (HRV2) and recombinant soluble VLDLR fragments have been used to identify the receptor-binding site on the virus surface. VLDLR contains eight N-terminal ligand-binding modules (V1-V8; Fig. 1 ). Modules V2 and V3 attach to the capsid protein VP1, specifically to the BC and HI loops 13, 14 . However, the resolution of these reconstructions was insufficient to establish neither the location of one module relative to the other receptor modules, nor the nature of the specific virus-receptor interactions.
RESULTS

Overall structure of the HRV2-receptor complex
The crystal structure of HRV2 in complex with a concatamer of V2 and V3 (V23) from VLDLR was determined at a resolution of 3.5 Å. The map clearly shows the presence of density corresponding to the receptor close to the viral five-fold axis (Fig. 2a,b) . This density could be interpreted, using the structure of repeat number 5 (L5) from LDLR 7, 8 , as corresponding to only one of the modules in a fragment of VLDLR encompassing modules V2 and V3. No density was visible for a second module. Discrimination between V2 and V3 was not evident in part because of the high sequence similarity of both modules (Fig. 3a) . However, some features in the density indicated the dominant presence of V3, in particular the insertion of Ala12-His13 and the two-residue deletion after Gln36 in V3 with respect to V2. The refined model of the receptor includes only V3 residues Cys3-Asn41 (Cys113-Asn151 in SwissProt entry P98155), which leaves the N and C termini of adjacent modules within 10 Å of each other (Fig. 2b) .
Density for the receptor was only slightly weaker than for the virus and the model was refined with a receptor occupancy of 80%. In the averaged model, the presence of some percentage of V2 in the same disposition as V3 introduces only minor differences that would be mostly compatible with the available density. In fact, it is possible that V2-V3 pairs are bound to adjacent binding sites, taking into account that terminal regions seem highly flexible in single repeats 15 and linker residues could easily bridge the gap between the C and N termini of adjacent modules. Cryo-EM studies with different minireceptors have shown, as indicated earlier, that V2 and V3 can both bind to HRV2, leaving similar footprints on the viral surface 13, 14 . However, V2 has a lower cell protection activity than V3 ( Table 1) , probably because it binds with lower affinity. Therefore, incubation conditions, in particular V23 concentration, might favor attachment by both modules or just by one of them (V3).
The structure of the determined VLDLR module V3 in complex with HRV2 consists of two loops that are connected by three disulfide bridges resulting in essentially the same fold observed in module 5 (L5) of LDLR 7, 8 and in other closely related repeats [15] [16] [17] [18] . No large conformational change is seen in the HRV2 structure bound to the receptor as compared with the structure of the uncomplexed HRV2 (ref. 19) ; only local rearrangements in residues Ala1087, Asn1088 and Lys1228, which interact directly with the receptor, are seen. As in HRV2 alone 19 , in the HRV2-receptor complex, density corresponding to the pocket factor and modeled as a fatty acid was found inside the hydrophobic pocket of VP1. This is expected because in HRV2 the receptor-binding site on the virus surface lies far from the pocket located in the canyon floor. The pocket factor is thus not expelled on receptor binding, as is believed to occur upon ICAM-1 binding in the canyon of major group HRVs 20 .
Interacting surfaces HRV2 interacts with the V3 receptor residues Gln16 and Trp22 and the acidic cluster involved in Ca 2+ coordination that includes Asp25-Gly-Glu-Asn-Asp29 (Fig. 3a) . The total solvent-accessible surface area buried in the interaction is 430 Å 2 . As compared with other protein complexes 21 , this area is very small; this might explain the low affinity of the interaction between virus and single receptor modules. The strength of the interaction increases upon concatenation of the repeats presumably by avidity effects due to multivalent attachment ( Table 1 and see below). The side chain of Trp22, which protrudes from the receptor module, establishes hydrophobic interactions with the aliphatic part of the Lys1224 side chain and with the side chain of Ile1226, both of which are at the apex of the HI loop, and with Leu1132 in the DE loop contributed by the adjacent VP1 subunit (Fig. 3b,c) . In turn, the side chain of Glu27, which contributes its backbone oxygen to the chelation of the Ca 2+ ion, establishes hydrogen bonds with the main chain nitrogen atoms of Ala1087 and Asn1088 in the BC loop. Through its carboxylate, it also forms a salt bridge with Lys1224. This lysine establishes additional electrostatic interactions with the negatively charged environment surrounding the Ca 2+ ion, in particular with Asp29. As mentioned above, the receptor module also contacts a second copy of VP1 stemming from the neighboring protomer; these contacts, in addition to the hydrophobic contact between Trp22 and Leu1132, include the hydrogen bonds of Gln16 with Thr1085 and Lys1228, located within the VP1 loops BC and HI, respectively (Fig. 3b,c) . Notably, the receptor-binding site on the viral surface is also accessible to antibodies, and the BC loop, which is directly involved in the virus-receptor interactions, forms the immunogenic site A. This is similar to the situation in FMDV, where the receptorbinding site is located in the dominant immunogenic loop 22 . A T1085K mutation in HRV2 allows it to escape neutralization by a monoclonal antibody 23 . This indicates relatively great freedom for changes at this position, and is consistent with the variation of this residue in the other minor group serotypes (Fig. 3b) .
The structure of the complex explains the central role of the tryptophan and the acidic cluster. A tryptophan, equivalent to Trp22 in V3, is also present in VLDLR modules V1, V2, V5 and V6 (Fig. 3a) . The acidic cluster presents only small differences among modules with a glutamate (underlined) between the two aspartates (DGEND) in V3 and an aspartate in V1, V2, V5 and V6.
DISCUSSION
Comparison with other HRV serotypes
How are all minor group HRVs recognized by the same receptor? Lys1224 is the only viral residue contacting the receptor that is strictly conserved in all minor group HRVs (Fig. 3b,c) 24 . Exchange of this lysine by site-directed mutagenesis in HRV2 for residues present at the equivalent position in major group HRVs caused lack of recovery of virus upon transfection of the mutagenized viral RNA into HeLa cells 25 . It is the key residue interacting with the negatively charged cluster and Trp22. In addition, the polar nature of the residue (Thr1085 in HRV2) that interacts with Gln16 is conserved in all other minor group serotypes. Furthermore, a hydrophobic residue is usually present at the position equivalent to Ile1226, with the exceptions of HRV1A and HRV1B, which have a lysine and a glutamate, respectively (Fig. 3b) . In these serotypes, the aliphatic tails of the lysine and of the glutamate may play a similar role as Ile1226 in preserving the hydrophobic interaction with Trp22. Although Leu1132 and Lys1228 are not conserved, other hydrophobic and basic residues are nearby. Therefore, it seems that the different minor group HRVs can retain the interactions required to bind the same receptor, though probably with some differences in the geometry of the receptor attachment. The elec- trostatic attraction between the ε-amino group of Lys1224 and the acidic cluster in the receptor modules could initiate the encounter between virus and receptor. The hydrophobic part of the aliphatic chain of the lysine would then be sandwiched between the conserved tryptophan and the (functionally) conserved hydrophobic residues nearby, in a process resembling a tool being slid onto a shaft or bolt. Tighter binding might involve further adjustments to the differences in the interacting surfaces. Why do major group HRVs fail to bind LDL receptors? All sequenced major group viruses, with the exception of HRV85, lack the lysine in their HI loop; this indicates a critical role for this residue in the recognition of minor group viruses 25 . HRV85 shows only small sequence differences with respect to HRV2 residues interacting with the receptor and this serotype might acquire LDLR-binding activity with just a few changes.
Comparison with natural ligands
The intermolecular interactions in the HRV2-receptor complex are markedly similar to the intramolecular interactions in LDLR at pH 5.3 between its β-propeller and module L5 (ref. 8) . In this case, Lys582 in the β-propeller establishes ionic interactions with the acidic cluster of L5 involving Asp196 and Asp200 (underlined) of DGGPD (Fig. 3c,d) ; this indicates that the negative potential of the acidic cluster around the Ca 2+ , even in the absence of a central aspartate or glutamate, suffices to attract the ε-amino group of the lysine. There are also hydrophobic interactions between Trp193 in L5 and the side chains of Glu581 and Lys582 of the β-propeller 8 . Although blade 5 of the β-propeller and L5 seem to associate at pH <6, HRV2 dissociates from its receptors at low pH 26 . This might be due to the contribution of histidine protonation to both the strengthening of intramolecular bonds, by increasing ionic interactions 8 , and the weakening of intermolecular contacts. In HRV minor group serotypes, several histidine residues cluster at the VP1-VP1 interfaces near the five-fold axes (His1138, His1173, His1225, His1227 and His1230 in HRV2). Modulation of the VP1 interactions between neighbor subunits is expected to also affect receptor binding across the edge of adjacent VP1 subunits.
VLDLR probably has only a limited role in minor group HRV infection because this receptor is not ubiquitously expressed as are LRP and, in particular, LDLR 27 . Unexpectedly, HRV1A binds much more strongly to mouse LDLR than to the human homolog 28 . Using human-mouse LDLR chimeras, we have recently shown that replacement of human L5 with the murine sequence strongly increases HRV1A binding. Human L1, L2, L4 and L5 contain the essential tryptophan but there is no glutamate between the two aspartates in the acidic clusters, whereas glutamate is present in mouse L5. Its introduction into human L5 by site-directed mutagenesis increased binding of HRV2 weakly and of HRV1A strongly 40 . This suggests that the increase of the negative potential at the acidic cluster augments the electrostatic interaction with Lys1224 and provides a tentative explanation for the higher binding affinity of the viruses for the mouse homolog of LDLR. Taken together, these results indicate that, similarly to V3 in VLDLR, L5 in LDLR has a central role in minor group HRV recognition.
Concatenation of repeat V3 increases binding
We have previously shown that various soluble LDLR-and VLDLRderived fragments protect HeLa cells from infection with minor group HRVs 5, 29, 30 . We have also observed that concatenation of V3 substantially increases cell protection for constructs with up to five modules (V33333 ; Table 1 and R.M., L. Snyers, J. Wruss and D.B., University of Vienna, and H. Peters and T. Peters, Institute of Chemistry, University of Lübeck, unpublished data). Indeed, this latter recombinant protein neutralizes all minor group HRVs, although to different extents, showing that an identical module can bind to all minor group serotypes (Fig. 4) .
The structure of the complex shows that adjacent modules could easily be connected around the five-fold axis (Fig. 2b) . This view is strengthened by taking into account the residues not included in the structure but present in the V3 concatamers (thus, a proline absent in the natural receptor was introduced between the modules during construction). Several modules present in a single receptor molecule, with linkers of suitable length and flexibility, might thus attach to symmetry-related binding sites on the viral surface, thereby greatly enhancing the binding strength. Such a molecule would form a ringlike structure firmly attached to the starlike platform on the five-fold symmetry axis of the virus and strongly inhibit infection, as observed in our experiments.
Although LDLR was discovered almost 30 years ago 31 , we are only now getting a glance at the recognition of a ligand by a binding module of the LDLR family. It is unexpected that the first structure of a complex solved by X-ray crystallography is that of a virus and not of a natural ligand bound to this receptor. It is also notable that the interface resembles closely that of the L5 module interacting with the β-propeller present in the same molecule 8 . An acidic cluster present in nearly all ligand-binding modules of the members of the LDLR family arranged around a central Ca 2+ ion, and a tryptophan conserved in most modules have a central role in the recognition of a lysine strictly conserved in all minor group HRVs. This unique combination of a hydrophobic and an ionic interaction is the basis of virus-binding specificity. Nevertheless, residues in the vicinity must contribute and these probably modulate the affinity of the receptors for the different serotypes. Clarifying these interactions will further the understanding of receptor recognition of the various ligands of the LDLR family. 
METHODS
Preparation of HRV2, minireceptor fragments and cell protection assays. HRV2 was grown in HeLa-H1 cells in suspension cultures and purified as described 13 . Recombinant VLDL minireceptor fragments were cloned into a pMAL-c2x vector (New England Biolabs) with a maltose-binding protein (MBP) fused to the N terminus and a His 6 -tag fused to the C terminus. The receptor fragments were then purified over Ni-nitriloacetic acid columns (Qiagen), oxidized and folded in the presence of the chaperone glutathione S-transferase receptor-associated protein (GST-RAP) immobilized on Sepharose as described 32 . For preparation of the V23 fragment without MBP, the material was cleaved with factor Xa 13 . Cell protection assays were carried out essentially as described for LDLR fragments 30 . Briefly, HeLa-H1 cells grown in 96-well plates were challenged, for some defined length of time, with the HRV serotypes in the presence of different concentrations of the purified receptor fragments. Cells were maintained at 34 °C and stained with crystal violet (Fig. 4 and Table 1 ).
Crystallization and data collection. Purified HRV2 and V23 were incubated overnight at 4 °C at a molar ratio of ∼1:120 to form the complex before the crystallization experiments. Orthorhombic crystals belonging to space group P2 1 22 1 (a = 308.7 Å, b = 352.2 Å, c = 380.5 Å) were obtained at room temperature by vapor diffusion in hanging drops of 3 µl of the complex solution (2 mg ml -1 in 50 mM Tris-HCl, pH 7.4) with an equal or smaller volume of a reservoir solution containing 0.6 M ammonium sulfate and 0.1 M sodium-potassium phosphate at pH 7.0. Crystals were cryoprotected by soaking for 1 min in a solution containing 30% (v/v) glycerol in the crystallization buffer. A data set, with a completeness of 72% to a resolution of 3.5 Å, was collected from three crystals cooled with liquid nitrogen and using synchrotron radiation (European Synchrotron Radiation Facility, Grenoble, beamlines ID14.4 and ID29) with ADSC Quantum detectors ( Table 2) . Diffraction images were processed using DENZO 33 .
Structure determination. Unit cell parameters, self-rotation and modulation of intensities according to a pseudo body-centered cell indicated that packing in the HRV2-V23 crystals was similar to the packing of the isolated HRV2 (space group I222), in which three icosahedral two-fold axes were coincident with three crystallographic two-fold axes 19 . In space group P2 1 22 1 one of the icosahedral two-fold axes coincides with the crystallographic two-fold on cell axis b, leaving half a virus particle in the crystal asymmetric unit. Therefore, positioning of a virus particle in the crystal of the complex had only two degrees of freedom: the translation along and the rotation around the b axis. Systematic searches carried out using the coordinates of native HRV2 with X-PLOR 34 gave a translation of 0.69 Å and a rotation of -1.6°with a sharp R-factor decrease from 51.1% to 36.3% for data in the resolution shell of 40.0-4.5 Å. At this point, a 2F o -F c map was calculated to 3.5 Å and used as the starting point for cycles of 30-fold noncrystallographic averaging and solvent flattening using GAP 35 . The averaging and solvent masks used covered the whole asymmetric unit. Correlation coefficients between observed and averaged structure factors gave values rising from 0.64 to 0.86 in the first and final cycles, respectively. The resulting map clearly showed extra density not corresponding to the HRV2 model that could be interpreted using the coordinates of the structure of the L5 module from LDLR 7, 8 . TURBO 36 and O 37 were used to rebuild the model and to incorporate the appropriate sequence changes. Discrimination between V2 and V3 modules was not obvious because sequences corresponding to the clearest map region, mainly from Cys17 to Asp35 (using the numbering of V3), are very similar for both modules (Fig. 3a) . A preliminary refinement was done with CNS 38 for data in the resolution shell of 15.0-3.5 Å using the coordinates from HRV2 and from the receptor module corresponding to the V3 fragment Cys17-Asp35 only. The resulting 2F o -F c map was again iteratively improved by density modification cycles to a final correlation coefficient of 0.89 using updated averaging and solvent masks. Some features in the final map, in particular the two-residue insertion Ala12-His13 and the two-residue deletion after Glu36 in V3 with respect to V2, suggest the dominant presence of V3 and the refinement was done taking into account V3 only, with an 80% of occupancy of the module. However, the presence of V2 is still possible, in particular owing to the binding of the V23 concatamer with both modules occupying adjacent binding sites as discussed in the text. Iterative positional and temperature refinement using CNS with noncrystallographic symmetry constraints and bulk solvent correction was alternated with manual model rebuilding. The model also includes a fatty acid that was found in the hydrophobic pocket of VP1. The final R-factor for the model was 28.5% with 86% of the receptor residues in the most favored regions of the Ramachandran plot and with none of the residues in disallowed regions. PROCHECK 39 was used to monitor the geometry of the model ( Table 2) .
Coordinates. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (accession code 1V9U). 
